Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Robert

Showing results (41-50 of 512) with videos related to

Pageof 52
Sort By:
Current Opinion in Oncology|December 31, 2010
RAF inhibition and induction of cutaneous squamous cell carcinomaCaroline Robert, Jean-Philippe Arnault, Christine Mateus
Melanoma Research|September 5, 2020
Is it melanoma? Ask my dog!Charles Velter, Ambre Marzouki-Zerouali, Caroline Robert
Seminars in Oncology|May 13, 2015
Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapiesAlexander M M Eggermont, Michele Maio, Caroline Robert
The New England Journal of Medicine|August 9, 2018
Adjuvant Pembrolizumab in Resected Stage III MelanomaAlexander M M Eggermont, Caroline Robert, Stefan Suciu
The Lancet. Oncology|July 1, 2021
Adjuvant therapy in stage IIIA melanoma - Authors' replyAlexander M M Eggermont, Stefan Suciu, Caroline Robert
Cancer Research|September 2, 2021
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy ResistanceMichaël Cerezo, Caroline Robert, Lunxu Liu, et al.
La Revue Du Praticien|June 23, 2021
[Treatment of melanoma with immune checkpoints inhibitors]Jeremy Lupu, Pierre Hamann, Émilie Routier, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2018
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort studyTony Ibrahim, Christine Mateus, Maria Baz, et al.
Nature Reviews. Clinical Oncology|June 1, 2018
The new era of adjuvant therapies for melanomaAlexander M M Eggermont, Caroline Robert, Antoni Ribas
Clinical, Cosmetic and Investigational Dermatology|June 16, 2011
Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatmentLinda Chami, Nathalie Lassau, Mohamed Chebil, et al.
Pageof 52

Showing results (41-50 of 512) with videos related to

Sort By:
Pageof 52
Current Opinion in Oncology|December 31, 2010
RAF inhibition and induction of cutaneous squamous cell carcinomaCaroline Robert, Jean-Philippe Arnault, Christine Mateus
Melanoma Research|September 5, 2020
Is it melanoma? Ask my dog!Charles Velter, Ambre Marzouki-Zerouali, Caroline Robert
Seminars in Oncology|May 13, 2015
Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapiesAlexander M M Eggermont, Michele Maio, Caroline Robert
The New England Journal of Medicine|August 9, 2018
Adjuvant Pembrolizumab in Resected Stage III MelanomaAlexander M M Eggermont, Caroline Robert, Stefan Suciu
The Lancet. Oncology|July 1, 2021
Adjuvant therapy in stage IIIA melanoma - Authors' replyAlexander M M Eggermont, Stefan Suciu, Caroline Robert
Cancer Research|September 2, 2021
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy ResistanceMichaël Cerezo, Caroline Robert, Lunxu Liu, et al.
La Revue Du Praticien|June 23, 2021
[Treatment of melanoma with immune checkpoints inhibitors]Jeremy Lupu, Pierre Hamann, Émilie Routier, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2018
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort studyTony Ibrahim, Christine Mateus, Maria Baz, et al.
Nature Reviews. Clinical Oncology|June 1, 2018
The new era of adjuvant therapies for melanomaAlexander M M Eggermont, Caroline Robert, Antoni Ribas
Clinical, Cosmetic and Investigational Dermatology|June 16, 2011
Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatmentLinda Chami, Nathalie Lassau, Mohamed Chebil, et al.
Pageof 52